HomeInsights52 Week High Stocks

Zydus Lifesciences Ltd 52 Week High

Zydus Lifesciences Ltd 52 Week High

stocks purchased

₹ 1.6 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

16.7 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 24, 2024

Image

Zydus Lifesciences Ltd

NSE: ZYDUSLIFE

YEARHIGH

₹ 1323.9

Last updated on: Nov 22, 2024

Key Highlights

  • The 52 Week HIGH of Zydus Lifesciences Ltd is ₹ 1323 as of 22 Nov 24 .

Company Fundamentals for Zydus Lifesciences Ltd

No data available

Market Price of Zydus Lifesciences Ltd

1M

1Y

3Y

5Y

Monitoring Zydus Lifesciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 2024948.7
21 Nov 2024944.25
19 Nov 2024946.9
18 Nov 2024944.95
14 Nov 2024958.05
13 Nov 2024963.6
12 Nov 2024950.1
11 Nov 2024968.55
08 Nov 2024968.65
07 Nov 2024972.6

Asset Value vs Market Value of Zydus Lifesciences Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Zydus Lifesciences Ltd

No data available

* All values are in crore

Historical Net Profit of Zydus Lifesciences Ltd

No data available

* All values are in crore

Zydus Lifesciences Ltd News Hub

News

Zydus Life Q2 PAT rises 14% YoY to Rs 911 cr

Revenue from operations grew 19.87% year on year (YoY) to Rs 5,237 crore in the quarter en...

Read more

12 Nov 202415:22

News

Zydus Lifesciences to table results

Zydus Lifesciences will hold a meeting of the Board of Directors of the Company on 12 Nove...

Read more

31 Oct 202411:58

News

Zydus Life rises on in-principle approval from WHO for typhoid vaccine

ZyVac TCV is now eligible for purchase by United Nations (UN) agencies. It is indigenously...

Read more

23 Oct 202414:50

News

Zydus receives USFDA approval for Fludrocortisone Acetate Tablets

Zydus Lifesciences has received final approval from the United States Food and Drug Admini...

Read more

18 Oct 202409:29

News

Zydus Life gets final approval from USFDA for Fludrocortisone Acetate tab

Fludrocortisone Acetate tablets are indicated as partial replacement therapy for primary a...

Read more

18 Oct 202412:47

News

Zydus partners with ICMR to initiate Phase 2 clinical trials of Desidustat oral tablet for treating sickle cell disease

Zydus Lifesciences has formalized the Memorandum of Agreement (MoA) with Indian Council of...

Read more

15 Oct 202410:08

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of Zydus Lifesciences Ltd

What is the significance of Zydus Lifesciences Ltd reaching its 52-week high?

Zydus Lifesciences Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Zydus Lifesciences Ltd 52-week high?

Investors monitor Zydus Lifesciences Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Zydus Lifesciences Ltd a good buy when it hits its 52-week high?

Whether Zydus Lifesciences Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Zydus Lifesciences Ltd fundamentals.

What should I consider before investing in Zydus Lifesciences Ltd at its 52-week high?

Before investing in Zydus Lifesciences Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Zydus Lifesciences Ltd stock price continue to rise after reaching its 52-week high?

Zydus Lifesciences Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*